Compare STC & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STC | PRGO |
|---|---|---|
| Founded | 1893 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | N/A | 1991 |
| Metric | STC | PRGO |
|---|---|---|
| Price | $67.80 | $14.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $81.00 | $20.33 |
| AVG Volume (30 Days) | 278.3K | ★ 2.5M |
| Earning Date | 02-04-2026 | 02-26-2026 |
| Dividend Yield | 3.07% | ★ 8.10% |
| EPS Growth | ★ 69.60 | N/A |
| EPS | ★ 3.60 | N/A |
| Revenue | $2,796,513,000.00 | ★ $4,281,800,000.00 |
| Revenue This Year | $17.75 | N/A |
| Revenue Next Year | $13.92 | N/A |
| P/E Ratio | $18.99 | ★ N/A |
| Revenue Growth | ★ 16.09 | N/A |
| 52 Week Low | $56.39 | $12.17 |
| 52 Week High | $78.61 | $30.93 |
| Indicator | STC | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 46.87 | 44.36 |
| Support Level | $66.33 | $13.58 |
| Resistance Level | $68.38 | $15.17 |
| Average True Range (ATR) | 1.58 | 0.53 |
| MACD | 0.34 | -0.09 |
| Stochastic Oscillator | 57.14 | 26.18 |
Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.